Live Breaking News & Updates on Vesalius biocapital

Stay informed with the latest breaking news from Vesalius biocapital on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Vesalius biocapital and stay connected to the pulse of your community

Begbies to meet expectations; McBride shines

The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:
----------
Begbies Traynor Group PLC - Manchester, England-based...

United-states , Austria , Idaho , Australia , Phoenix , Arizona , Romsey , Hampshire , United-kingdom , London , City-of , Canada

Memo Therapeutics AG Raises CHF 25 Million Series C Financing to Complete Phase II Clinical Developm

Series C led by Pureos BioventuresFinancing to support completion of a Phase II trial of AntiBKV and to prepare manufacturing of drug for Phase IIISCHLIEREN / ZURICH, Switzerland--(BUSINESS WIRE)--Memo Therapeutics AG (“MTx”), a late-stage biotech company developing best-in-class therapeutic antibodies, announced to...

Switzerland , Zurich , Züsz , Veronica-gambillara-fonck , Pureos-bioventures , Elias-papatheodorou , Mike-sinclair , Gf-group , Memo-therapeutics , Vesalius-biocapital , Adjuvant-capital , Verve-ventures

Memo Therapeutics raises $27.7 million to develop antibody treatment

The Swiss biotech company Memo Therapeutics (MTx) has bagged CHF 25 million ($27.7 million) in a Series C round to finish the phase 2 development of its lead antibody treatment.

Japan , Japanese , Pureos-bioventures , Veronica-gambillara-fonck , Drug-administration , Vesalius-biocapital , Fast-track , Vera-therapeutics , Bio-developments , Arkets-amp-regulations , Ipelines , Ntibody-drug-conjugates

AgeX Therapeutics Reports Second Quarter 2023 Financial Results

ALAMEDA, Calif.--(BUSINESS WIRE)--AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for the quarter and six months ended June 30, 2023.Balance Sheet InformationCash, cash equivalents, an...

Alabama , United-states , Paris , France-general- , France , American , America , Michaeld-west , Jean-christophe-renondin , Transition-services , Hackett , Cognate-bioservices

AgeX Therapeutics Reports Second Quarter 2023 Financial Results

AgeX Therapeutics, Inc. , a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for the quarter and six months ended June 30,...
-Today at 04:06 pm- MarketScreener

Alabama , United-states , Paris , France-general- , France , America , American , Jean-christophe-renondin , Michaeld-west , Juvenescence-limited , Serina-therapeutics-inc , Linkedin

Meet the VC: Vesalius Biocapital

In our “meet the VC” series, Delano is talking to local venture capitalists to discover their firms and their perspectives on the field. In this edition, Fabienne Roussel introduces us to Vesalius Biocapital and discusses healthtech in Luxembourg.

Portugal , Luxembourg , Lisbon , Lisboa , Paris , France-general- , France , Finland , Germany , Belgium , Amsterdam , Noord-holland

Vesalius Biocapital Announces First Close of Fourth Fund Raising EUR 95 Million

/PRNewswire/ -- Vesalius Biocapital, the specialist life sciences venture capital investor, announces the first close of its fourth fund, Vesalius Biocapital...

Luxembourg , Strassen , United-states , China , American , Chinese , David-cristina , Worg-pharma , Astellas-pharma , Stephane-heymans , Fabienne-roussel , Marjut-falkstedt

Vesalius Biocapital Holds First Close of Fourth Fund Raising EUR 95M

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

China , Luxembourg , Chinese , Jean-christophe-renondin , Worg-pharma , David-cristina , Qasim-zawawi , Fabienne-roussel , Stephane-heymans , Astellas-pharma , Olivier-houben , Sword-health